BioMelbourne Network
Progressing BioIndustry

News and Opinions

Previous1 | 2 | 3 | 4 | 5

2015

August

STA: License Agreement with PharmaMar to Market, Distribute Oncology Drug APLIDIN® (plitidepsin) in AU and NZ

21 August 2015.  Australian biopharmaceutical company Specialised Therapeutics Australia has struck an exclusive license and commercialisation agreement with European pharmaceutical partner company PharmaMar to market and distribute the novel oncology drug APLIDIN® (plitidepsin) in Australia and New Zealand. Under the terms of the agreement, PharmaMar will receive an upfront payment, royalties... read more…

Gordagen Receives $1.1m R&D Tax Incentive to Progress Clinical Development Program

18 August 2015.  Gordagen Pharmaceuticals, an Australian private company developing and commercialising tocotrienol-based biopharmaceuticals and nutraceuticals, is pleased to announce it has received a Research and Development Tax Incentive refund of AUD$1.1 million for the 2014/2015 financial year. Gordagen intends to apply these funds to continue progressing its ICH-GCP clinical development p... read more…

Invion Completes Clinical Trial of INV103 (ALA-CPN10) in Lupus Patients

17 August 2015.  Australian drug development  company  Invion  Limited  (ASX:  IVX)  has  completed  its  Phase  II  clinical  trial  entitled “Double-blinded,   randomised,   placebo-controlled   study   to   investigate   the   safety,   tolerability, pharmacokinetics, and biochemical activity of intravenous Cpn10 administration in subjects with SLE (NCT01838694)”.The Company’s decision to co... read more…

Science is Golden podcast episode 1: Dora Lush, the Australian scientist and war hero

17 August 2015.  Australian medical researcher Dora Lush died in the most heroic of circumstances, but you've probably never heard of her.Neither had I, and I write about Australian scientists for a living.While conducting experiments on the deadly scrub typhus infection in 1943 the young researcher pricked her finger with an infected needle.Within a week she had symptoms of the disease - fever... read more…

Gordagen Engages Ascendiant Capital Markets for Investment Banking Services

13 August 2015.  Gordagen Pharmaceuticals, a private biopharmaceutical and nutraceutical company developing and commercialising pharmaceuticals and nutraceuticals based on tocotrienols, today announced its engagement with Ascendiant Capital Markets LLC. to serve as the Company's U.S Investment Banker and corporate financial advisor.Dr. Glenn Tong, CEO and Managing Director of Gordagen Pharmaceu... read more…

IDT Australia Partners with ANI Pharmaceuticals to Commercialise IDT’s US Generic Drug Products

12 August 2015.  ANI Pharmaceuticals Inc. to become IDT’s US partner in the distribution of IDT’s generic drug products Targeting launch of the products in calendar 2016 IDT Australia Limited (IDT.AX) has completed a major commercial milestone with an agreement with US-based ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) to market and distribute in the US up to eighteen of IDT’s recently acqu... read more…

"When cities and regions flourish, our country flourishes" - Prime Minister Tony Abbott

6 August 2015. I couldn't agree more with this statement made by the PM this morning, when he announced a new Industry Growth Centre in Advanced Manufacturing for Deakin University. "Geelong will be the heart of advanced manufacturing in Australia" said Ian MacFarlane Minister for Industry and Science, who spoke of the amazing future Australia has in high-tech high-value manufacturing. Th... read more…

“Melbourne is the city that anchors Australia’s Innovation System”

3 August 2015.  Today Dr Krystal Evans CEO of the BioMelbourne Network gave evidence to the Senate Economics References Committee regarding the Senate Inquiry into Australia’s Innovation System. In her testimony she emphasised the need for a long-term vision for our nation’s future and consistent bi-partisan commitment to innovation. Dr Evans said that consultation with BioMelbourne Network mem... read more…
July

New Minister for Small Buiness, Innovation and Trade

31 July 2015.  The BioMelbourne Network welcomes the appointment of Victorian Upper House Labor MP Philip Dalidakis as the new Minister for Small Business, Innovation and Trade. We look forward to working the Minister in supporting innovative businesses and entrepreneurship in the biotechnology and medical technology sector. Melbourne is the city that anchors Australia’s innovation ecosystem. ... read more…

Gordagen Appoints Gregory Macosko to Board of Directors

29 July 2015.  Gordagen Pharmaceuticals, a private biopharmaceutical and nutraceutical company developing tocotrienols, today announced the appointment of Gregory Macosko to its board of directors, effective August 1, 2015.  With this addition, its Board now consists of 5 directors of which 3 directors are non-executive and independent.Mr. Fred Nadjarian, the Chairman of Gordagen Pharmaceutical... read more…